PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Jun-2022 FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis Sanofi
08-Jun-2022 Future Digital Award Winners Announced for Digital Health Innovation 2022 Juniper Research
08-Jun-2022 ImaginAb and Roche have entered a clinical trial supply agreement for provision of atezolizumab (Tecentriq®)1 to Non-Small Cell Lung Cancer Patients Enrolled in ImaginAb’s iPREDICT Phase IIb Study ImaginAb Inc.
08-Jun-2022 Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers Ariceum Therapeutics
08-Jun-2022 University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody Screening and Characterization University of Manchester
08-Jun-2022 Synklino completes Series A raise of EUR 29.8 million to advance clinical trials of its drug candidate for the treatment of Cytomegalovirus (CMV) Synklino
08-Jun-2022 Diurnal to present research into new treatments of Congenital Adrenal Hyperplasia (CAH) at ENDO 2022 Diurnal Group plc
08-Jun-2022 Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth Sanofi
08-Jun-2022 Douglas GmbH: DOUGLAS commits to a more sustainable beauty industry – clean beauty, diversity and climate protection as top priorities Douglas GmbH
08-Jun-2022 ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2 ProteoGenix
08-Jun-2022 Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001 Relief Therapeutics Holding SA
08-Jun-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report First Quarter 2022 Financial Results on June 15, 2022 Vivoryon Therapeutics N.V.
07-Jun-2022 IGEA Pharma N.V.: IGEA PHARMA HAS SIGNED A PRELIMINARY AGREEMENT WITH LMH-AN INDUSTRIAL HOLDING COMPANY-FOR A EURO 6.000.000 COMMITTMENT TO FUND THE COMPLETION OF ITS SWISS CBD EXTRACTION FACILITY IGEA Pharma N.V.
07-Jun-2022 Janssen Presents Initial Results from the Phase 2 RAGNAR Study of Erdafitinib in Patients with Advanced Solid Tumours with FGFR Alterations Janssen
07-Jun-2022 Diurnal to present research into new treatments of Congenital Adrenal Hyperplasia (CAH) at ENDO 2022 Diurnal
07-Jun-2022 CYTENA Enters Long Term OEM Supply Agreement with PAIA and Launches the F.QUANT Titer, High-Throughput Titer Quantification Assays for Antibodies and Fc Fusion Proteins B3C newswire
07-Jun-2022 Sanofi launches 2022 global Employee Stock Purchase Plan for 86.000 people Sanofi
07-Jun-2022 AnHeart Therapeutics and Innovent Biologics Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1 Inhibitor) at ASCO 2022 AnHeart Therapeutics
07-Jun-2022 Santhera Announces Corporate Calendar Update Santhera Pharmaceuticals
07-Jun-2022 Santhera Announces Improved Liquidity Position Santhera Pharmaceuticals